4//SEC Filing
Arbuckle Stuart A 4
Accession 0000875320-25-000196
CIK 0000875320other
Filed
May 14, 8:00 PM ET
Accepted
May 15, 4:10 PM ET
Size
5.6 KB
Accession
0000875320-25-000196
Insider Transaction Report
Form 4
Arbuckle Stuart A
EVP\Chief Commercial Officer
Transactions
- Award
Common Stock
2025-05-13+37,622→ 100,611 total
Holdings
- 140(indirect: By 401(k))
Common Stock
Footnotes (1)
- [F1]Represents earned performance shares with respect to a performance stock unit award granted on 12/06/2022 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 05/13/2025 and the shares will vest on 07/01/2025.
Documents
Issuer
VERTEX PHARMACEUTICALS INC / MA
CIK 0000875320
Entity typeother
Related Parties
1- filerCIK 0001557290
Filing Metadata
- Form type
- 4
- Filed
- May 14, 8:00 PM ET
- Accepted
- May 15, 4:10 PM ET
- Size
- 5.6 KB